THEX1 Antilichaam - N-terminalgebied: FITC (ARP41157_P050-FITC)

Exoribonuclease 1

HEXO, THEX1, 3'HEXO

90459

Q8IV48

NP_699163

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Pig, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human THEX1

THEX1 contains 1 SAP domain and 1 exonuclease domain. It is an RNA exonuclease that binds to the 3' end of histone mRNAs and probably degrades them, suggesting that it plays an essential role in histone mRNA decay after replication. It is also able to degrade the 3' overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi) .

UBC; HNRNPD; HHV8GK18_gp81; SLBP

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 93%; Dog: 100%; Guinea Pig: 86%; Horse: 86%; Human: 100%; Mouse: 85%; Pig: 93%; Rabbit: 100%; Rat: 79%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

40kDa

Kupsco, J.M., (2006) RNA 12 (12), 2103-2117

Wet Ice

349

ERI1

ERI1

Rabbit

3'-5' exoribonuclease 1

NM_153332

EPPRPSPEETQQCKFDGQETKGSKFITSSASDFSDPVYKEIAITNGCINR